Pharmaceutical Product Supply – Bupivacaine with Epinephrine Injection

The contract outlines the supply of six units of Bupivacaine 0.500% w/v combined with Epinephrine 0.005 mg/mL in a 1:200,000 concentration, packaged in cartridges of 50 each, for medical use under strict quality and shelf-life standards mandated by DLA. This pharmaceutical product is intended for anesthesia applications and must fully comply with federal procurement requirements for safety, potency, and stability. The solicitation falls under the NAICS code 325412, indicating human pharmaceutical manufacturing, and is classified as a subcontract within the Department of Defense's Medical Supply Chain Pharmaceutical FSA. All deliveries must be performed to the designated FPO location with the zip code 96667, and responses are due by May 18, 2026, following a posting date of May 11, 2026. The procurement is managed through the DIBBS system under the reference number SPE2DP26T3369, with no specific set-aside provisions or point of contact details provided.